4 Topic Commentaries
Genetic Testing in Retinoblastoma: New Applications
-
Debarshi Mustafi, MD, PhD
Ophthalmology; Pediatric Retina/Retina Genetics
•University of Washington School of Medicine
Source“Depending on which copy you have, that could reflect the cancer’s severity and its likely response to chemotherapy,”
-
Jesse L. Berry, MD
Ophthalmology; Ocular Oncology
•USC Roski Eye Institute, Keck School of Medicine of USC; Children’s Hospital Los Angeles
Source“In fact, we found measurable amounts of tumor DNA — genetic information from the tumor that had previously been completely unavailable from an intact eye.”
-
James Hicks, PhD
Cancer Genomics; Molecular Biology
•USC Michelson Center for Convergent Bioscience; USC Dornsife College of Letters, Arts and Sciences
Source“These findings provide proof of principle that the aqueous humor can be used for a surrogate ‘liquid’ tumor biopsy,”
-
Thomas C. Lee, MD
Ophthalmology; Pediatric Ophthalmology/Ocular Oncology
•USC Roski Eye Institute, Keck School of Medicine of USC; Children’s Hospital Los Angeles
Source“Until now, we could only do genetic analysis — and base therapy on the specific pathologic tumor features — when there was no longer a possibility of saving the eye,”
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







